Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenglei Li

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Iscience|June 4, 2024
Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagusMengfei Liu, Hongrui Tian, Minmin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized TrialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2025
Absolute Risk Prediction for Esophageal Squamous Cell Carcinoma Adaptable to Regional Disease Burden across Diverse RegionsMengfei Liu, Yi Huang, Hongrui Tian, et al.
BMC Medicine|November 7, 2025
Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based studyMengfei Liu, Zeyu Yan, Anxiang Liu, et al.
BMC Cancer|May 14, 2026
Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a population-based nested case-control studyMengfei Liu, Hongrui Tian, Minmin Wang, et al.
BMC Medicine|December 18, 2025
Correction: Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based studyMengfei Liu, Zeyu Yan, Anxiang Liu, et al.
The Journal of Pathology|May 25, 2022
Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesionsMengfei Liu, Ying Liu, Ren Zhou, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 15, 2021
Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control studyFangfang Liu, Mengfei Liu, Ying Liu, et al.
Eclinicalmedicine|April 28, 2022
Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general populationMengfei Liu, Ren Zhou, Zhen Liu, et al.
American Journal of Epidemiology|January 5, 2019
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based StudyMengfei Liu, Zhonghu He, Chuanhai Guo, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Iscience|June 4, 2024
Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagusMengfei Liu, Hongrui Tian, Minmin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized TrialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2025
Absolute Risk Prediction for Esophageal Squamous Cell Carcinoma Adaptable to Regional Disease Burden across Diverse RegionsMengfei Liu, Yi Huang, Hongrui Tian, et al.
BMC Medicine|November 7, 2025
Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based studyMengfei Liu, Zeyu Yan, Anxiang Liu, et al.
BMC Cancer|May 14, 2026
Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a population-based nested case-control studyMengfei Liu, Hongrui Tian, Minmin Wang, et al.
BMC Medicine|December 18, 2025
Correction: Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based studyMengfei Liu, Zeyu Yan, Anxiang Liu, et al.
The Journal of Pathology|May 25, 2022
Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesionsMengfei Liu, Ying Liu, Ren Zhou, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 15, 2021
Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control studyFangfang Liu, Mengfei Liu, Ying Liu, et al.
Eclinicalmedicine|April 28, 2022
Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general populationMengfei Liu, Ren Zhou, Zhen Liu, et al.
American Journal of Epidemiology|January 5, 2019
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based StudyMengfei Liu, Zhonghu He, Chuanhai Guo, et al.
Pageof 9